STERIS PLC formerly Steris Corp was founded in October 9, 2014. The Company is a provider of infection prevention and other procedural products and services, focused on healthcare, pharmaceutical and research. It offers a mix of capital equipment products, such as sterilizers and surgical tables, and connectivity solutions such as operating room ('OR') integration; consumable products, such as detergents and skin care products, gastrointestinal ('GI') endoscopy accessories, and other products; services, including equipment installation and maintenance; and microbial reduction of medical devices, instrument and scope repair solutions, and laboratory testing services. The Company operates in four reportable business segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. Healthcare Products segment offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance and installation services, as well as consumables. Healthcare Specialty Services segment provides a range of specialty services for healthcare providers including hospital sterilization services, instrument and scope repairs, and linen management. Life Sciences segment offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities. Applied Sterilization Technologies segment offers contract sterilization and laboratory services for medical device and pharmaceutical Customers and others. The Company is subject to various laws and governmental regulations concerning environmental matters and employee safety and health in the United States and in other countries.
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.